Antiplatelet therapy for throboprophylaxis: the need for careful consideration of the evidence from randomised trials.

Examines the effectiveness of antiplatelet therapy for thromboprophylaxis. Reduction of the thromboembolism with the therapy and with subcutaneous heparin; Effects of the reduction of pulmonary embolism for people at higher risk; Effects of antiplatelet therapy on surgical bleeding.